ResMed obviously believe they still have legitimate grounds to challenge FPH, given the patent litigation is still proceeding. That's still a valid concern for shareholders.
Printable View
ResMed obviously believe they still have legitimate grounds to challenge FPH, given the patent litigation is still proceeding. That's still a valid concern for shareholders.
Anyone on here good at understanding Patent law? Would Res Med's withdrawal of this suit mean that they could not refile using the same evidence or brief? Is FPH out of the woods yet?
[QUOTE=RupertBear;666458]Been a bit of a roller coaster ride today! Up then down then up again....;)
Sure was ,bounced as high as $10.49 finished @ $10.18. I didn't have enough conviction (or nimbleness) but was thinking it may have been good to sell into this as i have a sneaky feeling that the downwards direction may resume, i don't know why and hope I'm wrong.
FPH is not out of the woods, the litigation could be endless...
FPH never should have swung at the big boys, RMD could play this game for years to come... I am far from an expert on patent law, however patent trolling is as easy as A.B.C in the U.S.A
FPH is a solid business with a bright future ahead... use the short term uncertainty to your advantage.
Is that what you are doing hardt; topping up.
Sorry, missed that (happens when you are holidaying on a tropical island ... just too many distractions through heat, beer, swimming pool and good food;);
FPH was for ages on my watchlist. Always looked like a good company but always too dear. I first bought in when the SP flirted with the MA200 - but set a stop which got me out again with a minor loss. Bought back when the uptrend started again (passing the MA100). I do see them as long term hold (well, this is the intention), but this does not mean that I will ignore the SP movements and the economic and political environment.
Might buy some more if it moves below $10 (but stays above or around MA100).